AMZN
Amazon.com, Inc.
AMZN has slightly lower modeled downside risk, despite its lower overall score.
PHIN
PHINIA Inc.
PHIN has a slight edge over AMZN overall, supported by stronger valuation and stronger fundamentals.
AMZN Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Healthy | |
| Weak | |
| Healthy |
AMZN's revenue, profitability and balance sheet are currently healthy, but its cash flow is weak.
PHIN Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Healthy | |
| Healthy | |
| Healthy |
PHIN's profitability, cash flow and balance sheet are currently healthy, and its revenue is stable.
AMZN PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Current | 22x | $267 | — |
| Forward | 27x | $267 | — |
| Cheap | 34x | $415 | +55% |
| Fair | 60x | $745 | +179% |
| Expensive | 102x | $1,262 | +372% |
Historical ranges are pointers, not guarantees.
AMZN has the edge over PHIN in the historical PE scenario, which offers more potential upside but is not a forecast.
PHIN PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 10x | $72.51 | — |
| Current | 15x | $72.51 | — |
| Cheap | 19x | $92.38 | +27% |
| Fair | 22x | $110 | +52% |
| Expensive | 25x | $121 | +67% |
Historical ranges are pointers, not guarantees.
PHIN's PE is in its cheap range at 15x. If earnings grow as analysts expect, today's price would be 10x next year's earnings.
AMZN Forward outlook
| Metric | Outlook |
|---|---|
| Strongly deteriorating | |
| Strong growth | |
| Growth | |
| Improving | |
| Moderate | |
| Moderate |
Analysts expect earnings and revenue growth for AMZN, with profitability improving.
PHIN Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Growth | |
| Improving | |
| Limited | |
| High |
PHIN has the edge over AMZN on the outlook, with more favorable valuation expectations.
AMZN Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $9.87 | -20% |
| Q3 2026 | $12.37 | +75% |
| Q2 2026 | $12.43 | +89% |
| Q1 2026 | $8.36 | +36% |
| Q4 2025 | $7.17 | +30% |
| Q3 2025 | $7.08 | +52% |
| Q2 2025 | $6.56 | +57% |
| Q1 2025 | $6.14 | +72% |
| Q4 2024 | $5.53 | +91% |
AMZN has the edge over PHIN on earnings, with more consistent year-over-year improvement.
PHIN Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $6.94 | +40% |
| Q3 2026 | $4.95 | +122% |
| Q2 2026 | $3.48 | +34% |
| Q1 2026 | $3.57 | +102% |
| Q4 2025 | $3.24 | +84% |
| Q3 2025 | $2.23 | -4.3% |
| Q2 2025 | $2.60 | +39% |
| Q1 2025 | $1.77 | -23% |
| Q4 2024 | $1.76 | -15% |
PHIN earned $4.95 per share over the past year, up 122% from the year before.
AMZN Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $201.9B | +12% |
| Q2 2026 | $200.6B | +20% |
| Q1 2026 | $181.5B | +17% |
| Q4 2025 | $213.4B | +14% |
| Q3 2025 | $180.2B | +13% |
| Q2 2025 | $167.7B | +13% |
| Q1 2025 | $155.7B | +8.6% |
| Q4 2024 | $187.8B | +10% |
AMZN has the edge over PHIN on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 14% | +4.2 points |
| Q2 2026 | 14% | +2.3 points |
| Q1 2026 | 13% | +1.3 points |
| Q4 2025 | 12% | +0.4 points |
| Q3 2025 | 9.7% | -1.3 points |
| Q2 2025 | 11% | +1.5 points |
| Q1 2025 | 12% | +1.1 points |
| Q4 2024 | 11% | +3.5 points |
AMZN has the edge over PHIN on profitability, with a higher operating margin.
PHIN Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $912M | +0.4% |
| Q2 2026 | $940M | +5.6% |
| Q1 2026 | $878M | +10% |
| Q4 2025 | $889M | +6.7% |
| Q3 2025 | $908M | +8.2% |
| Q2 2025 | $890M | +2.5% |
| Q1 2025 | $796M | -7.8% |
| Q4 2024 | $833M | -5.6% |
PHIN's revenue has grown year over year for six quarters in a row: $912M last quarter, about level with the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 9.2% | +5.5 points |
| Q2 2026 | 8.5% | -1.5 points |
| Q1 2026 | 7.9% | +0.1 points |
| Q4 2025 | 7.8% | +1.6 points |
| Q3 2025 | 3.7% | -4.1 points |
| Q2 2025 | 10% | +1.8 points |
| Q1 2025 | 7.8% | -0.4 points |
| Q4 2024 | 6.1% | -3.1 points |
PHIN's operating margin was 9.2% last quarter, up 5.5 points from the same quarter a year ago.
AMZN Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$34.8B | -8202% |
| Q2 2026 | -$8.8B | -2757% |
| Q1 2026 | -$18.2B | -$10.2B |
| Q4 2025 | $14.9B | -16% |
| Q3 2025 | $430M | -87% |
| Q2 2025 | $332M | -96% |
| Q1 2025 | -$8B | -297% |
| Q4 2024 | $17.8B | -36% |
AMZN's free cash flow was −$46.9B over the past year, against $10.6B the year before.
PHIN Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $70M | -25% |
| Q2 2026 | $69M | +200% |
| Q1 2026 | $21M | +320% |
| Q4 2025 | $67M | +26% |
| Q3 2025 | $93M | +33% |
| Q2 2025 | $23M | -75% |
| Q1 2025 | $5M | +$17M |
| Q4 2024 | $53M | +83% |
PHIN has the edge over AMZN on cash generation, producing positive trailing cash flow while its opponent burns cash.
AMZN Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.2% | +26M shares |
| 1 year | +0.8% | +84M shares |
| 3 years | +3.5% | +371M shares |
| 5 years | +6.1% | +629M shares |
| Available history | +8.2% | +829M shares |
AMZN has 10.9B diluted shares, up 0.8% from a year ago.
| Quarter | Spent |
|---|---|
| Q1 2024 | — |
| Q4 2023 | — |
| Q3 2023 | — |
| Q2 2023 | — |
| Q1 2023 | — |
| Q4 2022 | — |
| Q3 2022 | — |
| Q2 2022 | $3.3B |
PHIN Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -2.4% | -900K shares |
| 1 year | -6.3% | -2.5M shares |
| 3 years | -21% | -10M shares |
PHIN has the edge over AMZN on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q1 2023 | — |
| Q4 2022 | — |
| Q3 2022 | — |
| Q2 2022 | — |
| Q1 2022 | — |
AMZN Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.7x | Very low |
| Q2 2026 | 0.3x | Very low |
| Q1 2026 | 0.1x | Very low |
| Q4 2025 | -0.1x | Net Cash |
| Q3 2025 | -0.1x | Net Cash |
| Q2 2025 | -0.0x | Net Cash |
| Q1 2025 | -0.1x | Net Cash |
| Q4 2024 | -0.2x | Net Cash |
AMZN has the edge over PHIN on leverage, with a lower net debt burden relative to earnings.
PHIN Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 1.4x | Healthy |
| Q2 2026 | 1.6x | Healthy |
| Q1 2026 | 1.6x | Healthy |
| Q4 2025 | 1.5x | Healthy |
| Q3 2025 | 1.6x | Healthy |
| Q2 2025 | 1.5x | Healthy |
| Q1 2025 | 1.5x | Healthy |
| Q4 2024 | 1.2x | Healthy |
PHIN's net debt is about 1.4 years of its operating earnings (EBITDA), down from 1.6 years a year ago.
AMZN Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 57.1 | Neutral |
| Stochastic | 50.0 | Neutral |
AMZN's weekly RSI is 57 (neutral) and its Stochastic is 50 (neutral).
PHIN Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 56.2 | Neutral |
| Stochastic | 55.5 | Neutral |
PHIN's weekly RSI is 56 (neutral) and its Stochastic is 55 (neutral).
AMZN PE vs Consumer Cyclical Sector
| Metric | AMZN | Sector median | Relative |
|---|---|---|---|
| PE | 22x | 18x | 20% above |
| PE % | 4 | 47 | 43 pts below |
AMZN is trading at 22x earnings, a 20% premium to the Consumer Cyclical sector's median of 18x, though its recent earnings include one-off gains.
PHIN PE vs Consumer Cyclical Sector
| Metric | PHIN | Sector median | Relative |
|---|---|---|---|
| PE | 15x | 18x | 19% below |
| PE % | 1 | 35 | 34 pts below |
PHIN has the edge over AMZN on valuation relative to its sector.
AMZN Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $253.6 | 5.5% above |
| 20 week MA | $254.9 | 4.9% above |
| 50 week MA | $242.5 | 10% above |
| 100 week MA | $229.6 | 17% above |
| 200 week MA | $191.4 | 40% above |
PHIN has stronger trend alignment. AMZN is above 5 of 5 weekly averages versus PHIN above 4 of 4.
PHIN Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $62.4 | 16% above |
| 20 week MA | $68.6 | 5.6% above |
| 50 week MA | $70.2 | 3.3% above |
| 100 week MA | $59.6 | 22% above |
PHIN is in an uptrend: it's above all four of its weekly moving averages, and 22% above its 100-week average.
AMZN Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $93.5 | $158.6 | +70% |
| 2021 | $158.6 | $171.1 | +7.8% |
| 2022 | $171.1 | $85.3 | -50% |
| 2023 | $85.3 | $151.9 | +78% |
| 2024 | $151.9 | $223.8 | +47% |
| 2025 | $223.8 | $232.5 | +3.9% |
| 2026 YTD | $232.5 | $267.4 | +15% |
AMZN has finished higher in five of the last six years, two of them by more than 50%. It's up 15% so far in 2026.
PHIN Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2023 | $31.5 | $30.3 | -3.8% |
| 2024 | $30.3 | $48.2 | +59% |
| 2025 | $48.2 | $61.4 | +27% |
| 2026 YTD | $61.4 | $72.5 | +18% |
PHIN has the edge over AMZN on returns for 2026, with the stronger performance.